DK28985D0 - Stabilt humant gamma-interferonpraeparat samt fremgangsmaade til fremstilling deraf - Google Patents

Stabilt humant gamma-interferonpraeparat samt fremgangsmaade til fremstilling deraf

Info

Publication number
DK28985D0
DK28985D0 DK28985A DK28985A DK28985D0 DK 28985 D0 DK28985 D0 DK 28985D0 DK 28985 A DK28985 A DK 28985A DK 28985 A DK28985 A DK 28985A DK 28985 D0 DK28985 D0 DK 28985D0
Authority
DK
Denmark
Prior art keywords
humant
preparing
procedure
stable
gamma interferon
Prior art date
Application number
DK28985A
Other languages
English (en)
Other versions
DK28985A (da
Inventor
Y Akagi
Y Miura
Y Hoshino
Original Assignee
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP59010857A external-priority patent/JPS60155136A/ja
Priority claimed from JP60002585A external-priority patent/JPS61161222A/ja
Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd
Publication of DK28985D0 publication Critical patent/DK28985D0/da
Publication of DK28985A publication Critical patent/DK28985A/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/555—Interferons [IFN]
    • C07K14/57—IFN-gamma
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/811—Interferon
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/14—Lymphokine; related peptides
    • Y10S930/142—Interferon

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Toxicology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Inorganic Chemistry (AREA)
  • Dermatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
DK28985A 1984-01-23 1985-01-22 Stabilt humant gamma-interferonpraeparat samt fremgangsmaade til fremstilling deraf DK28985A (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP59010857A JPS60155136A (ja) 1984-01-23 1984-01-23 γ型インタ−フエロン組成物
JP60002585A JPS61161222A (ja) 1985-01-09 1985-01-09 γ型インタ−フエロンフラグメントの組成物

Publications (2)

Publication Number Publication Date
DK28985D0 true DK28985D0 (da) 1985-01-22
DK28985A DK28985A (da) 1985-07-24

Family

ID=26336000

Family Applications (1)

Application Number Title Priority Date Filing Date
DK28985A DK28985A (da) 1984-01-23 1985-01-22 Stabilt humant gamma-interferonpraeparat samt fremgangsmaade til fremstilling deraf

Country Status (9)

Country Link
US (1) US4714611A (da)
EP (1) EP0150067A3 (da)
KR (1) KR850005455A (da)
AU (1) AU569365B2 (da)
DK (1) DK28985A (da)
GR (1) GR850158B (da)
NZ (1) NZ210897A (da)
PH (1) PH22531A (da)
PT (1) PT79854B (da)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5643566A (en) * 1982-09-23 1997-07-01 Cetus Corporation Formulation processes for lipophilic proteins
US5702699A (en) * 1982-09-23 1997-12-30 Cetus Corporation Process for the recovery of lipophilic proteins
IL75302A0 (en) * 1984-06-06 1985-09-29 Takeda Chemical Industries Ltd Novel polypeptide and production thereof
EP0168008A3 (en) * 1984-07-10 1986-12-30 Takeda Chemical Industries, Ltd. Stable composition of gamma-interferon
US4933433A (en) * 1986-01-31 1990-06-12 E. I. Du Pont De Nemours And Company Recombinant interleukin-2 composition and process for making it
DE3621828A1 (de) * 1986-06-28 1988-01-14 Biotest Pharma Gmbh Stabilisierung eines fuer therapeutische zwecke, insbesondere beim menschen, bestimmten interleukin-2-praeparates sowie dieses praeparat enthaltende stabilisierte waessrige loesung oder feststoff
US5183746A (en) * 1986-10-27 1993-02-02 Schering Aktiengesellschaft Formulation processes for pharmaceutical compositions of recombinant β-
CA1294215C (en) * 1986-10-27 1992-01-14 Ze'ev Shaked Pharmaceutical compositions of recombinant beta-interferon and formulation processes
US4895716A (en) * 1987-06-09 1990-01-23 Biogen, Inc. Stabilized formulations of gamma interferons
CA1327161C (en) * 1987-09-01 1994-02-22 Mitsugu Kobayashi Lyophilized pharmaceutical composition of neocarzinostatin derivative
US5151265A (en) * 1987-11-03 1992-09-29 Genentech, Inc. Gamma interferon formulation
US5078997A (en) * 1988-07-13 1992-01-07 Cetus Corporation Pharmaceutical composition for interleukin-2 containing physiologically compatible stabilizers
DE3900649A1 (de) * 1989-01-11 1990-07-12 Boehringer Mannheim Gmbh Verfahren zur abloesung eines analyten von seinem bindeprotein
LT3987B (en) 1992-02-17 1996-06-25 Fermentas Biotech Inst Stabilized interferon compositions
CN1175901C (zh) * 1999-12-06 2004-11-17 天津华立达生物工程有限公司 一种稳定的干扰素水溶液
US20030118598A1 (en) * 2000-02-08 2003-06-26 Allergan, Inc. Clostridial toxin pharmaceutical compositions
DK1253932T3 (da) * 2000-02-08 2005-06-27 Allergan Inc Lægemidler med botulinustoxin
US20060269575A1 (en) * 2000-02-08 2006-11-30 Allergan, Inc. Botulinum toxin pharmaceutical compositions formulated with recombinant albumin
US7780967B2 (en) 2000-02-08 2010-08-24 Allergan, Inc. Reduced toxicity Clostridial toxin pharmaceutical compositions
US8632785B2 (en) 2000-02-08 2014-01-21 Allergan, Inc. Clostridial toxin pharmaceutical composition containing a gelatin fragment
DE10204792A1 (de) * 2002-02-06 2003-08-14 Merck Patent Gmbh Lyophilisierte Zubereitung enthaltend Immuncytokine
US6982080B2 (en) * 2002-03-15 2006-01-03 Wyeth Hydroxyethyl starch—containing polypeptide compositions
ES2386972T3 (es) 2006-05-31 2012-09-10 Genzyme Corporation Uso de polisacáridos para la estimulación de la actividad enzimática
EP2288338A1 (en) * 2008-05-15 2011-03-02 Baxter International Inc. Stable pharmaceutical formulations
FI126979B (en) * 2016-02-29 2017-09-15 Faron Pharmaceuticals Oy Lyophilized pharmaceutical formulation and use thereof

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2244543B1 (da) * 1973-07-27 1977-07-01 Inst Nl Sante Rech Medica
US4100150A (en) * 1975-11-04 1978-07-11 G. D. Searle & Co. Stabilization of interferon against mechanical stress using thioctic acid
JPS5651995A (en) * 1979-10-05 1981-05-09 Green Cross Corp:The Preparation of interferon
JPS5821691A (ja) * 1981-07-29 1983-02-08 Mochida Pharmaceut Co Ltd α−及びβ−インタ−フェロンの精製方法
EP0080879B1 (en) * 1981-11-28 1986-10-01 Sunstar Kabushiki Kaisha Pharmaceutical composition containing interferon in stable state
EP0123291A2 (en) * 1983-04-20 1984-10-31 Kyowa Hakko Kogyo Co., Ltd. Method for stabilizing interferon
EP0168008A3 (en) * 1984-07-10 1986-12-30 Takeda Chemical Industries, Ltd. Stable composition of gamma-interferon

Also Published As

Publication number Publication date
KR850005455A (ko) 1985-08-26
DK28985A (da) 1985-07-24
AU569365B2 (en) 1988-01-28
PT79854B (en) 1986-12-15
PT79854A (en) 1985-02-01
EP0150067A3 (en) 1986-12-30
US4714611A (en) 1987-12-22
EP0150067A2 (en) 1985-07-31
PH22531A (en) 1988-10-17
GR850158B (da) 1985-05-21
NZ210897A (en) 1988-04-29
AU3801685A (en) 1985-08-01

Similar Documents

Publication Publication Date Title
DK28985D0 (da) Stabilt humant gamma-interferonpraeparat samt fremgangsmaade til fremstilling deraf
DK510384D0 (da) Laegemiddeltilberedning til intravenoes injektion samt fremgangsmaadetil fremstilling heraf
DK165248C (da) 1,3,9,9a-tetrahydro-imidazooe4,5-baaquinolin-2-oner samt fremgangsmaade til fremstilling deraf
DK328083D0 (da) Opvaskemiddel samt fremgangsmade til fremstilling deraf
DK307883D0 (da) Carbostyrilderivater samt fremgangsmade til fremstilling deraf
KR890701135A (ko) 감마 인터페론 제제
DK236185A (da) Stabiliseret insulin-formulering
KR860004915A (ko) 아미노아실라브단 및 이의 제조방법
DK114584A (da) Fast farmaceutisk praeparat samt fremgangsmaade til fremstilling deraf
DK163584C (da) 7-amino-3-propenylcephalosporinsyrederivater samt fremgangsmaade til fremstilling deraf
IT1186761B (it) Procedimento di preparazione di microlattici invertiti ed i microlattici invertiti ottenuti
DK131986D0 (da) Stabilt gammainterferonpraeparat
DK431185D0 (da) Substituerede quinazolindioner samt fremgangsmaade til fremstilling deraf
DK161086D0 (da) Nitrofuranderivater samt fremgangsmaade til fremstilling og anvendelse deraf
DK115685D0 (da) Prespap samt fremgangsmaade til fremstilling deraf
DK389085A (da) Vaccine-polypeptider
DK364483D0 (da) 14-aminosteroid-derivater samt fremgangsmade til fremstilling deraf
DK593985A (da) Olieadjuveret vaccine samt fremgangsmaade til fremstilling deraf
DK28885A (da) Hoejkoncentreret vandig human gamma-interferonoploesning samt fremgangsmaade til fremstilling deraf
DK504786A (da) Peptidforbindelser samt fremgangsmaade til fremstilling heraf
DK86785A (da) Bromcryptinpraeparater
DK404587D0 (da) 5-deoxy-5-flourkanamycin b-derivater samt fremgangsmaader til fremstilling deraf
DK401786D0 (da) Substituerede cyclohexanalkansyrer samt fremgangsmaade til fremstilling deraf
DK191684D0 (da) Hydroxylerede diphenylazomethinderivater samt fremgangsmaade til fremstilling deraf
ZA862140B (en) Stable gamma interferon formulation

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment